Research Paper Volume 16, Issue 1 pp 299—321
METTL3-dependent N6-methyladenosine modification is involved in berberine-mediated neuroprotection in ischemic stroke by enhancing the stability of NEAT1 in astrocytes
Figure 9. The schematic diagram of molecular mechanism in modulating METTL3-mediated m6A modification of NEAT1 in ischemic stroke by berberine via NEAT1/miR-377-3p/Nampt axis.